Solve Intelligence Raises $12 Million Backed by Microsoft and Thomson Reuters
Most patent work is being done inside Word, email, and PDF preview. There are a lot of inefficient and poor-quality workflows.
AI at work across drug discovery, clinical trials and life sciences.
Research: AIM Research reports on Pharma AI →Page 19
Most patent work is being done inside Word, email, and PDF preview. There are a lot of inefficient and poor-quality workflows.
AI voice assistants are the practical applications built using Voice AI
Previously, the company successfully secured $88 million in Series C funding to develop new products and enhance AI-based detection
The company has recently surpassed $300 million in ARR and is currently growing at a rate exceeding 30% year-over-year.
The company has set the ambitious goal of sequencing the genetic diversity of 10 million people this decade.
The organization's AI tool has streamlined the patent application process, reducing drafting time by up to 50% and saving legal professionals around two hours per day
OpsAI automates busywork, refines field notes, translates text, scans invoices and assets, and even assists with real-time troubleshooting
We believe that everyone deserves access to personalized, data-driven healthcare, and we are committed to making that a reality.
That’s why Charta is designed to be flexible and personalized, rather than a rigid, one-size-fits-all solution.
We’re building the product we always wished we had.
GB-0895 is one of the first large-scale tests of whether generative biology holds up in the clinic
The company connects quantum simulation and AI fine-tuning to life-science modeling
Now clinicians don’t have to choose between great patient care and work-life balance. They can have both.
Just asking ‘why’ helped DeepScribe be successful early on when a lot of folks native to healthcare took things for granted
Charta Health’s core advantage is its ability to work within existing healthcare infrastructure rather than attempting to replace it.
Their mission from day one was to equip IP professionals with the most powerful tools available to drive innovation and strategic success.
As startups push the boundaries of AI-powered healthcare, a new vision emerges which is intelligent agents driving precision medicine, optimising workflows, and transforming patient outcomes.
AI has the power to fundamentally change how we diagnose and deliver care, but it needs to work hand-in-hand with clinicians.
With Abridge, he’s creating a bridge to a future where clinicians can focus on what they do best: caring for their patients.
As AI capabilities expand, businesses that effectively manage and deploy AI agents will likely see the greatest competitive advantage in the years ahead.